[Treatment of angina pectoris and arrthymias with a beta receptor blockader].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000605:Amino Alcohols / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D010636:Phenols / Q000627:therapeutic use; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000627:therapeutic use; D011674:Pulse; D013565:Sympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010636:Phenols; D011437:Propylamines; D013565:Sympatholytics; D011433:Propranolol
Behandlung von Angina pectoris und Herzrhythmusstörungen mit einem Beta-Rezeptorenblocker.